5 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp05442 | Peptide-20 | CSSRTMHHC | Synthetic Peptide | Inducing apoptosis | MTT/MTS assay | A-2058 | Skin cancer | At100 µM 30% viablity |
| dbacp07242 | RB4 | MADSERLSAPGCWAACTNFSRTRK | Derived from protein PLP2 | F-actin modulation induces necrotic death. | MTT assay | A-2058 | Skin Cancer | EC50 = 0.744 ± 0.208 mol/L × 10-3 |
| dbacp08319 | Sample Peptide 2 from US011339203B2 | FIGNLALSDLLAGVAYTANLLLKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 assay | A-2058 | Skin Cancer | Cell Viability = 0.2% at 25 μM |
| dbacp08330 | Sample Peptide 1 from EP3604345B1 | MQIPQAPWPVVWAVLQLGWRKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | A-2058 | Skin Cancer | Cell Viability = 6.7% at 25 μM |
| dbacp08338 | Sample Peptide 3 from EP3604345B1 | MRIFAVFIFMTYWHLLNAKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | A-2058 | Skin Cancer | Cell Viability = 87.5% at 25 μM |